Centene (CNC) Stock Forecast & Price Target

Compare

2,597 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CNC Analyst Ratings

Moderate Buy

6 Buy

8 Hold

1 Sell

Based on 15 analysts giving stock ratings to

Centene

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CNC Stock 12 Month Forecast

Average Price Target

$48.54

▲(73.67%Upside)

Based on 15 Wall Street analysts offering 12 month price targets for Centene in the last 3 months. The average price target is $48.54 with a high forecast of $73.00 and a low forecast of $30.00. The average price target represents a 73.67% change from the last price of $27.95.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"29":"$29","54":"$54","79":"$79","41.5":"$41.5","66.5":"$66.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":73,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$73.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":48.54,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$48.54</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$30.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[29,41.5,54,66.5,79],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,56.65,57.90769230769231,59.16538461538462,60.42307692307692,61.68076923076923,62.93846153846154,64.19615384615385,65.45384615384616,66.71153846153847,67.96923076923076,69.22692307692307,70.48461538461538,71.74230769230769,{"y":73,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,56.65,56.026153846153846,55.402307692307694,54.778461538461535,54.15461538461538,53.53076923076923,52.90692307692308,52.28307692307692,51.65923076923077,51.035384615384615,50.41153846153846,49.7876923076923,49.16384615384615,{"y":48.54,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,56.65,54.6,52.55,50.5,48.45,46.4,44.35,42.3,40.25,38.2,36.15,34.1,32.05,{"y":30,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":65.34,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.91,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.83,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.94,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.52,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.06,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.58,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.03,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.16,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.45,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.41,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.91,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.65,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$73.00

Average Price Target$48.54

Lowest Price Target$30.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$32

Buy

14.49%

Upside

Reiterated

07/18/25

Centene's score is driven by strong financial performance and attractive valuation, which are partially offset by technical analysis indicating bearish market conditions. Positive earnings call sentiment supports the score, acknowledging the company's revenue growth and strategic achievements despite ongoing challenges.

David S MacdonaldTruist Financial

Truist Financial

$84→$42

Buy

50.27%

Upside

Reiterated

07/16/25

Centene price target lowered to $42 from $84 at TruistCentene price target lowered to $42 from $84 at Truist

Joanna GajukBank of America Securities

Bank of America Securities

$52→$30

Sell

7.33%

Upside

Downgraded

07/16/25

Centene downgraded to Underperform from Neutral at BofACentene downgraded to Underperform from Neutral at BofA

Lance WilkesBernstein

Bernstein

$86→$40

Buy

43.11%

Upside

Reiterated

07/16/25

Bernstein Keeps Their Buy Rating on Centene (CNC)

Michael WiederhornOppenheimer

Oppenheimer

$85→$51

Buy

82.47%

Upside

Reiterated

07/15/25

Oppenheimer Remains a Buy on Centene (CNC)

Ann HynesMizuho Securities

Mizuho Securities

$71→$40

Hold

43.11%

Upside

Reiterated

07/11/25

Centene price target lowered to $40 from $71 at MizuhoCentene price target lowered to $40 from $71 at Mizuho

Erin WrightMorgan Stanley

Morgan Stanley

$70→$33

Hold

18.07%

Upside

Downgraded

07/10/25

Centene (CNC) was downgraded to a Hold Rating at Morgan Stanley

Andrew Mok CFABarclays

Barclays

$45

Hold

61.00%

Upside

Reiterated

07/09/25

Barclays Sticks to Its Hold Rating for Centene (CNC)

Gary TaylorTD Cowen

TD Cowen

$73

Buy

161.18%

Upside

Reiterated

07/08/25

Analysts Offer Insights on Healthcare Companies: Astrana Health (NASDAQ: ASTH) and Centene (NYSE: CNC)

David WindleyJefferies

Jefferies

$61→$47

Hold

68.16%

Upside

Reiterated

07/02/25

Centene (CNC) Gets a Hold from Jefferies

A.J. RiceUBS

UBS

$80→$45

Hold

61.00%

Upside

Downgraded

07/02/25

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (NASDAQ: LQDA) and Centene (NYSE: CNC)

Justin LakeWolfe Research

Wolfe Research

―

Hold

―

Reiterated

07/02/25

Wolfe not a buyer of Centene on weakness given 2026 uncertaintyWolfe not a buyer of Centene on weakness given 2026 uncertainty

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$90→$65

Buy

132.56%

Upside

Reiterated

07/02/25

Centene price target lowered to $65 from $90 at Cantor FitzgeraldCentene price target lowered to $65 from $90 at Cantor Fitzgerald

John StanselJ.P. Morgan

J.P. Morgan

$75→$48

Hold

71.74%

Upside

Assigned

07/02/25

Centene's Financial Outlook: Hold Rating Amid Revenue Headwinds and Regulatory Uncertainties

Jason CassorlaGuggenheim

Guggenheim

―

Hold

―

Reiterated

07/02/25

Analysts Offer Insights on Healthcare Companies: Vera Therapeutics (NASDAQ: VERA), Apogee Therapeutics (NASDAQ: APGE) and Centene (NYSE: CNC)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$32

Buy

14.49%

Upside

Reiterated

07/18/25

David S MacdonaldTruist Financial

Truist Financial

$84→$42

Buy

50.27%

Upside

Reiterated

07/16/25

Centene price target lowered to $42 from $84 at TruistCentene price target lowered to $42 from $84 at Truist

Joanna GajukBank of America Securities

Bank of America Securities

$52→$30

Sell

7.33%

Upside

Downgraded

07/16/25

Centene downgraded to Underperform from Neutral at BofACentene downgraded to Underperform from Neutral at BofA

Lance WilkesBernstein

Bernstein

$86→$40

Buy

43.11%

Upside

Reiterated

07/16/25

Bernstein Keeps Their Buy Rating on Centene (CNC)

Michael WiederhornOppenheimer

Oppenheimer

$85→$51

Buy

82.47%

Upside

Reiterated

07/15/25

Oppenheimer Remains a Buy on Centene (CNC)

Ann HynesMizuho Securities

Mizuho Securities

$71→$40

Hold

43.11%

Upside

Reiterated

07/11/25

Centene price target lowered to $40 from $71 at MizuhoCentene price target lowered to $40 from $71 at Mizuho

Erin WrightMorgan Stanley

Morgan Stanley

$70→$33

Hold

18.07%

Upside

Downgraded

07/10/25

Centene (CNC) was downgraded to a Hold Rating at Morgan Stanley

Andrew Mok CFABarclays

Barclays

$45

Hold

61.00%

Upside

Reiterated

07/09/25

Barclays Sticks to Its Hold Rating for Centene (CNC)

Gary TaylorTD Cowen

TD Cowen

$73

Buy

161.18%

Upside

Reiterated

07/08/25

Analysts Offer Insights on Healthcare Companies: Astrana Health (NASDAQ: ASTH) and Centene (NYSE: CNC)

David WindleyJefferies

Jefferies

$61→$47

Hold

68.16%

Upside

Reiterated

07/02/25

Centene (CNC) Gets a Hold from Jefferies

A.J. RiceUBS

UBS

$80→$45

Hold

61.00%

Upside

Downgraded

07/02/25

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (NASDAQ: LQDA) and Centene (NYSE: CNC)

Justin LakeWolfe Research

Wolfe Research

―

Hold

―

Reiterated

07/02/25

Wolfe not a buyer of Centene on weakness given 2026 uncertaintyWolfe not a buyer of Centene on weakness given 2026 uncertainty

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$90→$65

Buy

132.56%

Upside

Reiterated

07/02/25

Centene price target lowered to $65 from $90 at Cantor FitzgeraldCentene price target lowered to $65 from $90 at Cantor Fitzgerald

John StanselJ.P. Morgan

J.P. Morgan

$75→$48

Hold

71.74%

Upside

Assigned

07/02/25

Centene's Financial Outlook: Hold Rating Amid Revenue Headwinds and Regulatory Uncertainties

Jason CassorlaGuggenheim

Guggenheim

―

Hold

―

Reiterated

07/02/25

Analysts Offer Insights on Healthcare Companies: Vera Therapeutics (NASDAQ: VERA), Apogee Therapeutics (NASDAQ: APGE) and Centene (NYSE: CNC)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Centene

1 Month

xxx

Success Rate

20/32 ratings generated profit

Average Return

+0.74%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 62.50% of your transactions generating a profit, with an average return of +0.74% per trade.

3 Months

xxx

Success Rate

35/53 ratings generated profit

Average Return

+3.23%

reiterated a xxx

rating 6 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.04% of your transactions generating a profit, with an average return of +3.23% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

29/53 ratings generated profit

Average Return

+7.79%

reiterated a buy rating 6 days ago

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 54.72% of your transactions generating a profit, with an average return of +7.79% per trade.

2 Years

xxx

Success Rate

18/32 ratings generated profit

Average Return

-2.00%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 56.25% of your transactions generating a profit, with an average return of -2.00% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CNC Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CNC has received 24 Buy Ratings, 11 Hold Ratings, and 1 Sell Ratings. CNC average Analyst price target in the past 3 months is 48.54.

Each month's total comprises the sum of three months' worth of ratings.

CNC Financial Forecast

CNC Earnings Forecast

Next quarter’s earnings estimate for CNC is $0.30 with a range of -$1.02 to $1.54. The previous quarter’s EPS was $2.90. CNC beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.08% of the time in the same period. In the last calendar year CNC has Outperformed its overall industry.

CNC Sales Forecast

Next quarter’s sales forecast for CNC is $44.34B with a range of $43.24B to $45.85B. The previous quarter’s sales results were $46.62B. CNC beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.46% of the time in the same period. In the last calendar year CNC has Outperformed its overall industry.

CNC Stock Forecast FAQ

What is CNC’s average 12-month price target, according to analysts?

Based on analyst ratings, Centene’s 12-month average price target is 48.54.

What is CNC’s upside potential, based on the analysts’ average price target?

Centene has 73.67% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CNC a Buy, Sell or Hold?

Centene has a consensus rating of Moderate Buy which is based on 6 buy ratings, 8 hold ratings and 1 sell ratings.

What is Centene’s price target?

The average price target for Centene is 48.54. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $73.00 ,the lowest forecast is $30.00. The average price target represents 73.67% Increase from the current price of $27.95.

What do analysts say about Centene?

Centene’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of CNC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Centene (CNC) Stock Forecast & Price Target

CNC Analyst Ratings

CNC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Centene

CNC Analyst Recommendation Trends

CNC Financial Forecast

CNC Earnings Forecast

CNC Sales Forecast

CNC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts